(S (NP (NP (JJ Prognostic) (NN information)) (PP (IN at) (NP (NN diagnosis)))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NN cancer) (NN treatment) (CC and) (NN monitoring))))) (. .))
(S (SBAR (IN Although) (S (NP (NP (NN cancer) (NN staging)) (, ,) (NP (JJ histopathological) (NN assessment)) (, ,) (NP (JJ molecular) (NNS features)) (, ,) (CC and) (NP (JJ clinical) (NNS variables))) (VP (MD can) (VP (VB provide) (NP (JJ useful) (JJ prognostic) (NNS insights)))))) (, ,) (S (VP (VBG improving) (NP (NN risk) (NN stratification)))) (VP (VBZ remains) (NP (DT an) (JJ active) (NN research) (NN area))) (. .))
(S (NP (PRP We)) (VP (VBD developed) (NP (DT a) (NML (JJ deep) (NN learning)) (NN system) (PRN (-LRB- -LRB-) (NP (NN DLS)) (-RRB- -RRB-))) (S (VP (TO to) (VP (VB predict) (NP (ADJP (NN disease) (JJ specific)) (NN survival)) (PP (IN across) (NP (NP (CD 10) (NN cancer) (NNS types)) (PP (IN from) (NP (DT The) (NML (NNP Cancer) (NNP Genome)) (NNP Atlas)))))))) (PRN (-LRB- -LRB-) (NP (NN TCGA)) (-RRB- -RRB-))) (. .))
(S (NP (PRP We)) (VP (VP (VBD used) (NP (DT a) (ADJP (RB weakly) (HYPH -) (JJ supervised)) (NN approach)) (PP (IN without) (NP (NN pixel) (HYPH -) (NML (NN level) (NNS annotations))))) (, ,) (CC and) (VP (VBD tested) (NP (CD three) (JJ different) (NML (NN survival) (NN loss)) (NNS functions)))) (. .))
(S (NP (DT The) (NNP DLS)) (VP (VBD was) (VP (VP (VBN developed) (S (VP (VBG using) (NP (CD 9,086) (NNS slides)) (PP (IN from) (NP (CD 3,664) (NNS cases)))))) (CC and) (VP (VBN evaluated) (S (VP (VBG using) (NP (CD 3,009) (NNS slides)) (PP (IN from) (NP (CD 1,216) (NNS cases)))))))) (. .))
(S (PP (IN In) (NP (NP (JJ multivariable) (NNP Cox) (NN regression) (NN analysis)) (PP (IN of) (NP (NP (DT the) (VBN combined) (NN cohort)) (PP (VBG including) (NP (DT all) (CD 10) (NNS cancers))))))) (, ,) (NP (DT the) (NNP DLS)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (IN with) (NP (NN disease) (JJ specific) (NN survival) (PRN (-LRB- -LRB-) (NP (NP (NP (NN hazard) (NN ratio)) (PP (IN of) (NP (CD 1.58)))) (, ,) (NP (NP (CD 95) (NN %)) (NP (NN CI) (CD 1.28) (HYPH -) (CD 1.70)))) (, ,) (S (NP (NN p)) (VP (SYM <) (NP (CD 0.0001)))) (-RRB- -RRB-)))) (PP (IN after) (S (VP (VBG adjusting) (PP (IN for) (NP (NN cancer) (NML (NN type) (, ,) (NN stage) (, ,) (NN age) (, ,) (CC and) (NN sex))))))))) (. .))
(S (PP (IN In) (NP (DT a) (NML (IN per) (HYPH -) (NN cancer)) (VBN adjusted) (NN subanalysis))) (, ,) (NP (DT the) (NNP DLS)) (VP (VBD remained) (NP (NP (DT a) (JJ significant) (NN predictor)) (PP (IN of) (NP (NN survival)))) (PP (IN in) (NP (NP (CD 5)) (PP (IN of) (NP (NML (CD 10) (NN cancer)) (NNS types)))))) (. .))
(S (PP (VBN Compared) (PP (IN to) (NP (NP (DT a) (NN baseline) (NN model)) (PP (VBG including) (NP (NN stage) (, ,) (NN age) (, ,) (CC and) (NN sex)))))) (, ,) (NP (NP (DT the) (NML (NN c) (HYPH -) (NN index))) (PP (IN of) (NP (DT the) (NN model)))) (VP (VBD demonstrated) (NP (DT an) (JJ absolute) (CD 3.7) (NN %)) (NP (NP (NN improvement) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NN CI) (CD 1.0) (HYPH -) (CD 6.5)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (VBN combined) (NN cohort))))) (. .))
(FRAG (ADVP (RB Additionally)) (, ,) (FRAG (NP (PRP$ our) (NNS models)) (NP (JJ stratified) (NNS patients)) (PP (IN within) (NP (JJ individual) (NN cancer) (NNS stages)))) (, ,) (FRAG (ADVP (RB particularly)) (NP (NN stage) (NML (NML (CD II) (PRN (-LRB- -LRB-) (S (NP (NN p)) (VP (SYM =) (NP (CD 0.025)))) (-RRB- -RRB-))) (CC and) (NML (NN stage) (CD III) (PRN (-LRB- -LRB-) (S (NP (NN p)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-)))))) (. .))
(S (PP (IN By) (S (VP (VBG developing) (CC and) (VBG evaluating) (NP (JJ prognostic) (NNS models)) (PP (IN across) (NP (JJ multiple) (NN cancer) (NNS types)))))) (, ,) (NP (DT this) (NN work)) (VP (VBZ represents) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ comprehensive)) (NNS studies)) (VP (VBG exploring) (NP (NP (DT the) (JJ direct) (NN prediction)) (PP (IN of) (NP (JJ clinical) (NNS outcomes)))) (S (VP (VBG using) (NP (JJ deep) (NML (NN learning) (CC and) (NN histopathology)) (NNS images))))))))) (. .))
(S (NP (PRP$ Our) (NN analysis)) (VP (VBZ demonstrates) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (DT this) (NN approach) (S (VP (TO to) (VP (VB provide) (NP (JJ prognostic) (NN information)) (PP (PP (IN in) (NP (JJ multiple) (NN cancer) (NNS types))) (, ,) (CC and) (ADVP (RB even)) (PP (IN within) (NP (JJ specific) (JJ pathologic) (NNS stages))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (VBN given) (NP (NP (DT the) (ADJP (RB relatively) (JJ small)) (NN number)) (PP (IN of) (NP (JJ clinical) (NNS events))))) (, ,) (NP (PRP we)) (VP (VBD observed) (ADVP (RB wide) (NP (NN confidence) (NNS intervals))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ future) (NN work)) (VP (MD will) (VP (VB benefit) (PP (IN from) (NP (JJR larger) (NNS datasets)))))))))) (. .))
